by Maria Zannes | Jun 8, 2021 | Events
Dr. Elzi will present his poster “Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors” at the University of Massachusetts RNA Therapeutics Symposium: From Concept to Clinic, June 23-25, 2021. Dr. Elzi’s live presentation will...
by Maria Zannes | Mar 20, 2021 | Articles, News
Local CEO: New recommendations acknowledge that women and Black people are at higher risk than white men MARCH 19, 2021 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San-Antonio Business Journal Several major national medical...
by Maria Zannes | Mar 3, 2021 | Press Releases
MARCH 3, 2021 (SAN ANTONIO, TX) Peer-Reviewed Paper Explains How Porphyrins Used in Company’s Diagnostic and Therapeutic Platforms Enter Cancer Cells bioAffinity Technologies, a privately held company focused on early diagnostics and cancer therapeutics, announced...
by Maria Zannes | Feb 16, 2021 | Events
Dr. David Elzi will present the poster “Meso-tetra (4-carboMeso-tetra (4-carboxyphenyl) porphyrin (TCPP) is taken up in cancer cells by the CD320 receptor” at the International Conference on Porphyrins and Phthalocyanines (ICPP) ICPP-11 virtual from June 26 through...
by Maria Zannes | Feb 11, 2021 | News
FEBRUARY 8, 2021 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San-Antonio Business Journal “China represents a $5 billion market for CyPath© Lung. An estimated 780,000 people will be diagnosed annually in China with lung...
